欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Calicheamicin_108212-75-5_产品详情
108212-75-5
  • names:

    Calicheamicin

  • CAS号:

    108212-75-5

    MDL Number:
  • MF(分子式): C55H74IN3O21S4 MW(分子量): 1368.35
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Calicheamicin
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000901-5mg 5mg 98.44% ¥ 11475.00 ¥ 11475.00 2-3天
- +
¥ 0.00
YZM000901-1mg 1mg 98.44% ¥ 5200.00 ¥ 5200.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名 Calicheamicin
CAS号 108212-75-5
Inchi
InchiKey
分子式 Formula C55H74IN3O21S4
分子量 Molecular Weight 1368.35
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(73.08 mM)H2O< 0.1 mg/mL(insoluble)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionCalicheamicin, an antitumor antibiotic, is a cytotoxic agent that causes doubletrand DNA breaks. Calicheamicin is a DNA synthesis inhibitor.
Application1
Application2
Application3
Calicheamicin, an antitumor antibiotic, is a cytotoxic agent that causes double-strand DNA breaks. Calicheamicin is a DNA synthesis inhibitor.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Damelin M, et al. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clin Cancer Res. 2015 Sep 15;21(18):4165-73
【2】.de Vries JF, et al. The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells. Leukemia. 2012 Feb;26(2):255-64
【3】.Takeshita A, et al. CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Leukemia. 2009 Jul;23(7):1329-36.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents